Conclusion

Parvovirus B19, which generally provokes an acute but mild, self-limiting disease in children, can cause life-threatening disorders and chronic infection in immuno-compromised patients or patients with congenital hemo-lytic disorders. There is mounting evidence that B19 virus is an emerging pathogen for viral myocarditis and dilated cardiomyopathy. Currently available elaborate molecular

1. Weigel-Kelley, K.A.Yoder, M.C.; Srivastava, A. a5p1 Integrin as a cellular co-receptor for human parvovirus B19: Requirement of functional activation of p1 integrin for viral entry. Blood 2003, 102, 3927-3933.

2. Morita, E.; Nakashima, A.; Asao, H.; Sato, H.; Sugamura, K. Human parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G1 phase. J. Virol. 2003, 77, 2915 -2921.

3. Sol, N.; Le Junter, J.; Vassias, I.; Freyssinier, J.M.; Thomas, A.; Prigent, A.F.; Rudkin, B.B.; Fichelson, S.; Morinet, F. Possible interactions between the NS1 protein and tumor necrosis factor a pathways in erythroid cell apoptosis induced by human parvovirus B19. J. Virol. 1999, 73 (10), 8762 - 8770.

4. Dorsch, S.; Liebisch, G.; Kaufmann, B.; van Landenberg, P.; Hoffmann, J.H.; Drobnik, W.; Modrow, S. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J. Virol. 2002, 76, 20142018.

5. Heegard, E.D.; Brown, K.E. Human parvovirus B19. Clin. Microbiol. Rev. 2002, 15, 485 -505.

6. Valeur-Jensen, A.K.; Pedersen, C.B.; Westergaard, T.; Jensen, I.P.; Lebech, M.; Andersen, P.K.; Aaby, P.; Pedersen, B.N.; Melbye, M. Risk factors for parvovirus B19 infection in pregnancy. JAMA 1999, 281 (12), 10991105.

7. Daly, P.; Corcoran, A.; Mahon, P.B.; Doyle, S. High-sensitivity PCR detection of parvovirus B19 in plasma. J. Clin. Microbiol. 2002, 40 (6), 1958-1962.

8. Gallinella, G.; Venturoli, S.; Manaresi, E.; Musiani, M.; Zerbini, M. B19 virus genome diversity: Epidemiological and clinical correlations. J. Clin. Virol. 2003, 28 (1), 1-13.

9. Servant, A.; Laperche, S.; Lallemand, F.; Marinho, V.; de Saint Maur, G.; Meritet, J.F.; Garbarg-Chenon, A. Genetic diversity within human erythroviruses: Identification of three genotypes. J. Virol. 2002, 76, 9124-9134.

10. Brown, K.E.; Young, N.S. Parvovirus B19 infection and hematopoiesis. Blood Rev. 1995, 9, 176-182.

11. Srivastava, A.; Bruno, E.; Briddell, R.; Cooper, R.; Srivastava, C.; van Besien, K.; Hoffman, R. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood 1990, 76 (10), 1997-2004.

12. Bültmann, B.D.; Klingel, K.; Sotlar, K.; Bock, C.T.; Kandolf, R. Parvovirus B19: A pathogen responsible for more than hematologic disorders. Virchows Arch. 2003, 442, 8-17.

13. Yaegashi, N.; Niinüma, T.; Chisaka, H.; Watanabe, T.; Uehara, S.; Okamüra, K.; Moffatt, S.; Sügamüra, K.; Yajima, A. The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis. J. Infect. 1998, 37 (1), 28-35.

14. Tolfvenstam, T.; Papadogiannakis, N.; Norbeck, O.; Petersson, K.; Broliden, K. Freqüency of hüman parvovirus B19 infection in intraüterine fetal death. Lancet 2001, 357 (9267), 1494-1497.

15. Püblic Health Laboratory Service Working Party on Fifth Disease. Prospective stüdy of hüman parvovirus (B19) infection in pregnancy. Br. Med. J. 1990, 300 (6733), 1166-1170.

16. Rodis, J.F.; Rodner, C.; Hansen, A.A.; Borgida, A.F.; Deoliveira, I.; Shülman Rosengren, S. Long-term oütcome of children following maternal hüman parvovirüs B19 infection. Obstet. Gynecol. 1998, 91, 125-128.

17. Schowengerdt, K.O.; Ni, J.; Denfield, S.W.; Gajarski, R.J.; Bowles, N.E.; Rosenthal, G.; Kearney, D.L.; Price, J.K.; Rogers, B.B.; Schaüer, G.M.; Chinnock, R.E.; Towbin, J.A. Association of parvovirüs B19 genome in children with myocarditis and cardiac allograft rejection: Diagnosis üsing the polymerase chain reaction. Circülation 1997, 96, 3549-3554.

18. Panküweit, S.; Moll, R.; Baandrüp, U.; Portig, I.; Hüfnagel, G.; Maisch, B. Prevalence of the parvovirüs B19 genome in endomyocardial biopsy specimens. Hüm. Pathol. 2003, 34, 497-503.

19. Kühl, U.; Paüschinger, M.; Bock, T.; Klingel, K.; Schwimmbeck, C.P.; Seeberg, B.; Kraütwürm, L.; Poller, W.; Schültheiss, H.P.; Kandolf, R. Parvovirüs B19 infection mimicking acüte myocardial infarction. Circüla-tion 2003, 108, 945-950.

20. Gallinella, G.; Züffi, E.; Gentilomi, G.; Manaresi, E.; Ventüroli, S.; Bonvicini, F.; Cricca, M.; Zerbini, M.; Müsiani, M. Relevance of B19 markers in serüm samples for a diagnosis of parvovirüs B19-correlated diseases. J. Med. Virol. 2003, 71 (1), 135-139.

21. Harder, T.C.; Hüfnagel, M.; Zahn, K.; Beütel, K.; Schmitt, H.J.; Ullmann, U.; Raütenberg, P. New Light-Cycler PCR for rapid and sensitive qüantification of parvovirüs B19 DNA güides therapeütic decision-making in relapsing infections. J. Clin. Microbiol. 2001, 39, 4413-4419.

22. Balloü, W.R.; Reed, J.L.; Noble, W.; Yoüng, N.S.; Koenig, S. Safety and immünogenicity of a recombinant parvovirüs B19 vaccine formülated with MF59C.1. J. Infect. Dis. 2003, 187 (4), 675-678.

23. Hicks, K.E.; Beard, S.; Cohen, B.J.; Clewley, J.P. A simple and sensitive DNA hybridization assay üsed for the roütine diagnosis of hüman parvovirüs B19 infection. J. Clin. Microbiol. 1995, 33 (9), 2473-2475.

24. Dürignon, E.L.; Erdman, D.D.; Gary, G.W.; Pallansch, M.A.; Török, T.J.; Anderson, L.J. Mültiple primer pairs for polymerase chain reaction (PCR) amplification of hüman parvovirüs B19 DNA. J. Virol. Methods 1993, 44, 155165.

25. Zerbini, M.; Gentilomi, G.; Cricca, M.; Manaresi, E.; Bonvicini, F.; Müsiani, M. A system to enhance the sensitivity of digoxigenin-labelled probe: Detection of B19 DNA in serüm samples. J. Virol. Methods 2001, 93 (1-2), 137 - 144.

26. del Mar Mosqüera, M.; de Ory, F.; Moreno, M.; Echevarria, J.E. Simültaneoüs detection of measles virüs, rübella virüs, and parvovirüs B19 by üsing mültiplex PCR. J. Clin. Microbiol. 2002, 40 (1), 111-116.

27. Grüber, F.; Falkner, F.G.; Dorner, F.; Hammerle, T. Qüantitation of viral DNA by real-time PCR applying düplex amplification, internal standardization, and two-color flüorescence detection. Appl. Environ. Microbiol. 2001, 67 (6), 2837-2839.

Getting Started With Dumbbells

Getting Started With Dumbbells

The use of dumbbells gives you a much more comprehensive strengthening effect because the workout engages your stabilizer muscles, in addition to the muscle you may be pin-pointing. Without all of the belts and artificial stabilizers of a machine, you also engage your core muscles, which are your body's natural stabilizers.

Get My Free Ebook


Post a comment